ArticleFrontiers in immunology2025

The 41BB-agonist potentiates the therapeutic efficacy of a combined irreversible electroporation ablation treatment of lung cancer by promoting unexpected CD8

Chen Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.